Cargando…

Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma

Blocking cancer genomic instability may prevent tumor diversification and escape from therapies. We show that, after MAPK inhibitor (MAPKi) therapy in patients and mice bearing patient-derived xenografts (PDX), acquired resistant genomes of metastatic cutaneous melanoma specifically amplify resistan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dharanipragada, Prashanthi, Zhang, Xiao, Liu, Sixue, Lomeli, Shirley H., Hong, Aayoung, Wang, Yan, Yang, Zhentao, Lo, Kara Z., Vega-Crespo, Agustin, Ribas, Antoni, Moschos, Stergios J., Moriceau, Gatien, Lo, Roger S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068459/ https://www.ncbi.nlm.nih.gov/pubmed/36700848 http://dx.doi.org/10.1158/2159-8290.CD-22-0787

Ejemplares similares

Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired Resistance
por: Yang, Zhentao, et al.
Publicado: (2022)

Multi-organ landscape of therapy-resistant melanoma
por: Liu, Sixue, et al.
Publicado: (2023)

SPRED1 deletion confers resistance to MAPK inhibition in melanoma
por: Ablain, Julien, et al.
Publicado: (2020)

JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma
por: Titz, Bjoern, et al.
Publicado: (2016)

Melanoma whole exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance
por: Shi, Hubing, et al.
Publicado: (2012)

Targeted profiling of human extrachromosomal DNA by CRISPR-CATCH
por: Hung, King L., et al.
Publicado: (2022)

Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma
por: Liu, Sixue, et al.
Publicado: (2021)

Genome-wide characterization of copy number variations in diffuse large B-cell lymphoma with implications in targeted therapy
por: Dharanipragada, Prashanthi, et al.
Publicado: (2019)

In Silico Identification and Functional Characterization of Genetic Variations across DLBCL Cell Lines
por: Dharanipragada, Prashanthi, et al.
Publicado: (2023)

iCopyDAV: Integrated platform for copy number variations—Detection, annotation and visualization
por: Dharanipragada, Prashanthi, et al.
Publicado: (2018)

SeqVItA: Sequence Variant Identification and Annotation Platform for Next Generation Sequencing Data
por: Dharanipragada, Prashanthi, et al.
Publicado: (2018)

Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
por: Hernandez-Davies, Jenny E, et al.
Publicado: (2015)

Exosomes as a predictor tool of acquired resistance to melanoma treatment
por: Goedert, Lucas, et al.
Publicado: (2014)

Targeting wild-type TP53 using AMG 232 in combination with MAPK inhibition in Metastatic Melanoma; a phase 1 study
por: Moschos, Stergios J., et al.
Publicado: (2022)

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models
por: Gobin, Bérengère, et al.
Publicado: (2014)

Evolution of resistance to MAPK-targeted therapies
por: Lo, Roger
Publicado: (2015)

PAK Signaling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-mutant Melanomas
por: Lu, Hezhe, et al.
Publicado: (2017)

Chromosomal instability and acquired drug resistance in multiple myeloma
por: Wang, Wang, et al.
Publicado: (2017)

Adaptive and Acquired Resistance to EGFR Inhibitors Converge on the MAPK Pathway
por: Ma, Pengfei, et al.
Publicado: (2016)

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
por: Poulikakos, Poulikos I., et al.
Publicado: (2011)

Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma
por: Krayem, Mohamad, et al.
Publicado: (2020)

PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma
por: Ribas, Antoni, et al.
Publicado: (2020)

Multi-Omics Revealed Molecular Mechanisms Underlying Guard Cell Systemic Acquired Resistance
por: David, Lisa, et al.
Publicado: (2020)

Identification of DIR1-Dependant Cellular Responses in Guard Cell Systemic Acquired Resistance
por: David, Lisa, et al.
Publicado: (2021)

Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors
por: Escuin-Ordinas, Helena, et al.
Publicado: (2016)

Role of NPR1 in Systemic Acquired Stomatal Immunity
por: Guan, Qijie, et al.
Publicado: (2023)

MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor
por: Caenepeel, Sean, et al.
Publicado: (2017)

Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma
por: Ribas, Antoni, et al.
Publicado: (2021)

NH(4) (+) protects tomato plants against Pseudomonas syringae by activation of systemic acquired acclimation
por: Fernández-Crespo, Emma, et al.
Publicado: (2015)

Silencing of SPARC represses heterotopic ossification via inhibition of the MAPK signaling pathway
por: Wang, Qianjun, et al.
Publicado: (2019)

NatB regulates Rb mutant cell death and tumor growth by modulating EGFR/MAPK signaling through the N-end rule pathways
por: Sheng, Zhentao, et al.
Publicado: (2020)

Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumour microenvironment and cross-resistance to immunotherapy in melanoma
por: Haas, Lisa, et al.
Publicado: (2021)

N-hydroxypipecolic acid triggers systemic acquired resistance through extracellular NAD(P)
por: Li, Qi, et al.
Publicado: (2023)

Effect of Generational Status on Child Well-Being: Mediating Effects of Social Support and Residential Instability
por: Chan, Ko Ling, et al.
Publicado: (2019)

Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling
por: Tripathi, Rakshamani, et al.
Publicado: (2020)

Community-acquired pneumonia
por: Prina, Elena, et al.
Publicado: (2015)

Multiregional genetic evolution of metastatic uveal melanoma
por: Rodriguez, Daniel A., et al.
Publicado: (2021)

Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
por: Merida-Vieyra, Jocelin, et al.
Publicado: (2019)

p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes
por: Tivey, Hannah S. E., et al.
Publicado: (2012)

Retrotransposon instability dominates the acquired mutation landscape of mouse induced pluripotent stem cells
por: Gerdes, Patricia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nhk3o5isacov3pel9rbv0kukv4